Form 8-K - Current report:
SEC Accession No. 0001193125-22-203630
Filing Date
2022-07-27
Accepted
2022-07-27 17:19:40
Documents
13
Period of Report
2022-07-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d368588d8k.htm   iXBRL 8-K 24701
2 EX-99.1 d368588dex991.htm EX-99.1 75252
  Complete submission text file 0001193125-22-203630.txt   228009

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20220726.xsd EX-101.SCH 2843
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220726_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220726_pre.xml EX-101.PRE 10804
7 EXTRACTED XBRL INSTANCE DOCUMENT d368588d8k_htm.xml XML 3256
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 221111890
SIC: 2835 In Vitro & In Vivo Diagnostic Substances